All News #Library
Others
Sumitomo Pharma Presents New Vibegron Data at 2025 AUA Meeting
29 Apr 2025 //
PR NEWSWIRE
Sumitomo Pharma Get Approval for Gemtesa in Overactive Bladder
23 Dec 2024 //
PR NEWSWIRE
Sumitomo Pharma Presents Data on Nuvisertib and Enzomenib at ASH
09 Dec 2024 //
PR NEWSWIRE

Market Place
Sourcing Support